Single‐cell transcriptomic analysis reveals a metastasis‐associated <scp>PCSK1</scp> <sup>+</sup> neuroendocrine subpopulation in pancreatic neuroendocrine tumors

Pancreatic neuroendocrine tumors (PNETs) are uncommon malignancies characterized by significant clinical heterogeneity and a pronounced tendency for liver metastasis. Despite this, the cellular mechanisms driving PNET progression remain inadequately elucidated, especially concerning neuroendocrine subpopulations. We analyzed publicly available single-cell RNA sequencing (scRNA-seq) data from 27 samples, including adjacent normal tissues (NT), primary tumors (PT), and hepatic metastases (HM), to explore the heterogeneity of neuroendocrine cells. Our downstream analyses encompassed copy number variation (CNV) inference, pseudotime trajectory modeling using CytoTRACE2 and Monocle3, Single-Cell Regulatory Network Inference and Clustering (SCENIC), cell-cell communication analysis via CellChat, and external validation with bulk RNA-seq datasets. We identified a distinct PCSK1<sup>+</sup> neuroendocrine cell subpopulation, predominantly found in HM, which exhibited a high CNV burden, low differentiation potential, and significant transcriptional divergence from the NEUROD1<sup>+</sup> neuroendocrine cells prevalent in primary tumors. The trajectory analysis delineated a developmental continuum commencing from the NEUROD1<sup>+</sup> subpopulation and culminating in the PCSK1<sup>+</sup> subpopulation. SCENIC analysis identified ATF6 as a pivotal transcriptional regulator within the PCSK1<sup>+</sup> subpopulation, while KEGG enrichment of its target genes indicated involvement in stress-related signaling pathways. Furthermore, cell-cell communication analysis demonstrated that fibroblasts were the predominant signaling source to the PCSK1<sup>+</sup> subpopulation in both primary tumors (PT) and hepatic metastases (HM), with conserved ligand-receptor interactions, including the CD99-CD99 and collagen-integrin axes. Our study identifies a metastasis-enriched, terminally differentiated PCSK1<sup>+</sup> subpopulation and elucidates its potential regulatory and microenvironmental characteristics. These findings enhance our understanding of the cellular states linked to the progression of PNETs and lay the groundwork for subsequent mechanistic investigations.

Authors

Institutions

Publication Details

Journal
Journal of Neuroendocrinology
Published
2025-08-16
DOI
https://doi.org/10.1111/jne.70084
Citations
1
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single‐cell transcriptomic analysis reveals a metastasis‐associated PCSK1 + neuroendocrine subpopulation in pancreatic neuroendocrine tumors

Jiaojiao Hou, Xiaopeng Li, Xiaolei Yin, Fei Yin et al.
1 citations
Journal of Neuroendocrinology
Neuroendocrine Tumor Research Advances
1.35
article

Single‐cell transcriptomic analysis reveals a metastasis‐associated PCSK1 + neuroendocrine subpopulation in pancreatic neuroendocrine tumors

Jiaojiao Hou, Xiaopeng Li, Xiaolei Yin, Fei Yin, Lili Mi
article en
1 citations

Abstract

Pancreatic neuroendocrine tumors (PNETs) are uncommon malignancies characterized by significant clinical heterogeneity and a pronounced tendency for liver metastasis. Despite this, the cellular mechanisms driving PNET progression remain inadequately elucidated, especially concerning neuroendocrine subpopulations. We analyzed publicly available single-cell RNA sequencing (scRNA-seq) data from 27 samples, including adjacent normal tissues (NT), primary tumors (PT), and hepatic metastases (HM), to explore the heterogeneity of neuroendocrine cells. Our downstream analyses encompassed copy number variation (CNV) inference, pseudotime trajectory modeling using CytoTRACE2 and Monocle3, Single-Cell Regulatory Network Inference and Clustering (SCENIC), cell-cell communication analysis via CellChat, and external validation with bulk RNA-seq datasets. We identified a distinct PCSK1<sup>+</sup> neuroendocrine cell subpopulation, predominantly found in HM, which exhibited a high CNV burden, low differentiation potential, and significant transcriptional divergence from the NEUROD1<sup>+</sup> neuroendocrine cells prevalent in primary tumors. The trajectory analysis delineated a developmental continuum commencing from the NEUROD1<sup>+</sup> subpopulation and culminating in the PCSK1<sup>+</sup> subpopulation. SCENIC analysis identified ATF6 as a pivotal transcriptional regulator within the PCSK1<sup>+</sup> subpopulation, while KEGG enrichment of its target genes indicated involvement in stress-related signaling pathways. Furthermore, cell-cell communication analysis demonstrated that fibroblasts were the predominant signaling source to the PCSK1<sup>+</sup> subpopulation in both primary tumors (PT) and hepatic metastases (HM), with conserved ligand-receptor interactions, including the CD99-CD99 and collagen-integrin axes. Our study identifies a metastasis-enriched, terminally differentiated PCSK1<sup>+</sup> subpopulation and elucidates its potential regulatory and microenvironmental characteristics. These findings enhance our understanding of the cellular states linked to the progression of PNETs and lay the groundwork for subsequent mechanistic investigations.

Journal of NeuroendocrinologyVol. 37(11)
Hebei Medical University (CN), Fourth Hospital of Hebei Medical University (CN)
Good health and well-being
Openalex Percentile: Top 16%
Neuroendocrine Tumor Research Advances
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.